SINGLE-DOSE PHARMACOKINETICS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN PATIENTS WITH VARIOUS DEGREES OF RENAL-FAILURE

被引：64
|
作者：
KINDLER, J
ECKARDT, KU
EHMER, B
JANDELEIT, K
KURTZ, A
SCHREIBER, A
SCIGALLA, P
SIEBERTH, HG
机构：
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1989年 / 4卷 / 05期
关键词：
D O I：
10.1093/oxfordjournals.ndt.a091888
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：345 / 349
页数：5
相关论文
共 50 条
  • [31] Pharmacokinetics of intravenous, single-dose tiotropium in subjects with different degrees of renal impairment
    Türck, D
    Weber, W
    Sigmund, R
    Budde, K
    Neumayer, HH
    Fritsche, L
    Rominger, KL
    Feifel, U
    Slowinski, T
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (02): : 163 - 172
  • [32] PHARMACOKINETICS IN PATIENTS WITH RENAL-FAILURE
    MAHER, JF
    CLINICAL NEPHROLOGY, 1984, 21 (01) : 39 - 46
  • [33] EFFECTS OF HUMAN RECOMBINANT ERYTHROPOIETIN ON ANEMIA, SYSTEMIC HEMODYNAMICS AND RENAL-FUNCTION IN PREDIALYSIS RENAL-FAILURE PATIENTS
    ONOYAMA, K
    KUMAGAI, H
    TAKEDA, K
    SHIMAMATSU, K
    FUJISHIMA, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (11) : 966 - 970
  • [34] Pharmacokinetics of single-dose morinidazole in patients with severe renal impairment
    Zhang, Hao
    Huang, Lu
    Huang, Yuan-yuan
    Yi, Bin
    Pei, Qi
    Tan, Hong-yi
    Huang, Jie
    Liu, Ji-shi
    Yuan, Hong
    Yang, Guo-ping
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (02) : 159 - 165
  • [35] SINGLE-DOSE PHARMACOKINETICS OF PRAVASTATIN AND METABOLITES IN PATIENTS WITH RENAL IMPAIRMENT
    HALSTENSON, CE
    TRISCARI, J
    DEVAULT, A
    SHAPIRO, B
    KEANE, W
    PAN, H
    JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (02): : 124 - 132
  • [36] PHARMACOKINETICS AND DOSE RECOMMENDATIONS OF CARUMONAM IN RENAL-FAILURE
    KOEPPE, P
    HOFFLER, D
    STROBEL, K
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1987, 37-1 (01): : 65 - 69
  • [37] ERYTHROID PROGENITORS AND SERUM INHIBITORS OF ERYTHROPOIESIS IN HEMODIALYZED RENAL-FAILURE PATIENTS RECEIVING RECOMBINANT HUMAN ERYTHROPOIETIN
    REID, CDL
    FIDLER, J
    WINEARLS, CG
    OLIVER, DO
    COTES, PM
    BRITISH JOURNAL OF HAEMATOLOGY, 1988, 68 (04) : 507 - 507
  • [38] HEMOSTATIC ALTERATIONS ASSOCIATED WITH RECOMBINANT HUMAN ERYTHROPOIETIN (R-HUEPO) THERAPY IN PATIENTS WITH RENAL-FAILURE
    ALMOMEN, AK
    HURAIB, S
    MITWALLI, A
    SULIMANI, F
    ABUAISHA, H
    GADER, AMA
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 364 - 364
  • [39] DOES HUMAN RECOMBINANT ERYTHROPOIETIN INFLUENCE THE HEMOSTATIC BALANCE IN PATIENTS WITH END-STAGE RENAL-FAILURE
    JEPPESEN, L
    STENVER, D
    MEHLSEN, J
    HAEDERSDAL, C
    NIELSEN, B
    WINTHER, K
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1354 - 1354
  • [40] PHARMACOKINETICS OF SINGLE DOSE IV MORPHINE IN NORMAL VOLUNTEERS AND PATIENTS WITH END STAGE RENAL-FAILURE
    AITKENHEAD, AR
    VATER, M
    COOPER, CMS
    SMITH, G
    BRITISH JOURNAL OF ANAESTHESIA, 1983, 55 (09) : P905 - P905
12345